In the closing of the recent trading day, Okta (OKTA) stood at $92.1, denoting a +1.13% move from the preceding trading day.

Fintel reports that on July 7, 2025, Arete Research initiated coverage of Okta (NasdaqGS:OKTA) with a Sell recommendation.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy ...

Okta (OKTA) and Palo Alto Networks recently expanded their partnership with new integrations aimed at improving security solutions. Despite these positive developments, Okta's stock experienced a 6% ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $67.5 to $100.0 for Okta over the last 3 months. Looking at the ...

Okta, Inc. (NASDAQ:OKTA), the $17.2 billion identity management leader with impressive gross profit margins of nearly 77%, reported several developments following its annual meeting of ...

According to InvestingPro data, the company maintains strong financial health with positive net income and 13.5% revenue growth. Benjamin Horowitz informed Okta on June 20 that he would resign from ...

Analysts are estimating that FB Financial will report an earnings per share (EPS) of $0.88. The market awaits FB Financial's ...

Tariffs appear to be coming, but the 10-20% levy for more than 150 countries is less than the 35-50% tariffs many of them faced initially. This is perhaps something many investors accounted for when ...

Discover key insights from Fulton Financial's Q2 2025 earnings, including record $100.6M operating earnings, stronger guidance, and disciplined ...

BrightSpring Health Services, Inc. BTSG has raised its full-year 2025 financial outlook. The company now expects total revenues to be in the range of $12.0-$12.5 billion (up from $11.6-$12.1 ...

Boston Scientific lifts its 2025 sales and EPS outlook after a strong Q1, with cardiology and EP segments fueling major gains.